Nov 13 2006 | 12:23pm ET
For the second time this year, Third Point’s Daniel Loeb has used his activist hedge fund pulpit to win concession from portfolio company Nabi Biopharmaceuticals.
The Boca Raton, Fla.-based Nabi has appointed two Third Point nominees, hedge fund manager Jason Aryeh and NeuroStat Pharmaceuticals CEO Tim Lynch, to its board of directors. The two will also sit on a newly-constituted five-member strategic action committee, which is charged with evaluating strategic options and making recommendations to the board and management.
Dec 5 2013 | 9:51am ET
Do you have a job opening at your firm? Post a vacancy free for the month of April. Visit the FINalternatives Job Board and use code SNOW. Please only post job vacancies aimed at the asset management industry or related financial services professionals. Read more…